常荣凯,张培影

• 1:南京中医药大学
• 2:江苏省徐州市中心医院

摘要(Abstract)：

经皮冠状动脉介入治疗的发展极大降低了冠心病的病残率及死亡率,而术后再狭窄的问题依然影响着该项技术远期预后的评价。通过中西医结合的防治手段减少术后再狭窄的发生极具前景,值得深入研究、探讨。

关键词(KeyWords)： 冠心病;经皮冠状动脉介入治疗;再狭窄;中西医结合

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 常荣凯,张培影

参考文献(References)：

• [1]Looser PM,Kim LK,Feldman DN.In-stent restenosis:pathophysiology and treatment[J].Curr Treat Options Cardio Med,2016,18(2):10.
• [2]Rensing BJ,Hermans WR,Beatt KJ,et al.Quantitative angiographic assessment of elastic recoil after percutaneous transluminal coronary angioplasty[J].Am J Cardiol,1990,66(15):1039-1044.
• [3]Costa MA,Sabate M,Kay IP,et al.Three-dimensional intravascular ultrasonic volumetric quantification of stent recoil and neointimal formation of two new generation tubular stents[J].Am J Cardiol,2000,85(2):135-139.
• [4]吴轶喆,葛雷,沈雳,等.连续血管内超声评价完全可降解聚-L-乳酸支架置入猪冠状动脉1个月支架弹性回缩[J].中国介入心脏病学杂志,2013,21(3):172-177.
• [5]Li W,Wang H,Kuang CY,et al.An essential role for the Id1/PI3K/Akt/NF-κB/survivin signalling pathway in promoting the proliferation of endothelial progenitor cells in vitro[J].Mol Cell Biochem.2012,363(1-2):135-145.
• [6]Ostrowski SR,Johansson PI.Endothelial glycocalyx degradation induces endogenous heparinization in patients with severe injury and early traumatic coagulopathy[J].J Trauma Acute Care Surg,2012,73(1):60-66.
• [7]Park SJ,Kang SJ,Virmani R,et al.In-stent neoatherosclerosis:a final common pathway of late stent failure[J].J Am Coll Cardiol,2012,59(23):2051-2057.
• [8]Taguchi I,Yoneda S,Abe S,et al.The late-phase inflammatory response after drug-eluting stent implantation[J].Heart Vessels,2014,29(2):213-219.
• [9]Caixeta AM,Brito FS Jr,Costa MA,et al.Enhanced inflammatory response to coronary stenting marks the development of clinically relevant restenosis[J].Catheter Cardiovasc Interv,2007,69(4):500-507.
• [10]刘永胜,江华,刘文卫,等.冠心病PCI术后再狭窄患者IL-18、IL-10和基质金属蛋白酶-9水平的研究[J].国际检验医学杂志,2014,35(11):1431-1432.
• [11]Katsaros KM,Kastl SP,Zorn G,et al.Increased restenosis rate after implantation of drug-eluting stents in patients with elevated serum activity of matrix metalloproteinase-2 and-9[J].JACC Cardiovasc Interv,2010,3(1):90-97.
• [12]邓庆媛,叶益聪,钟颖,等.血管紧张素Ⅱ对行择期经皮冠状动脉介入治疗患者院内预后的预测作用[J].协和医学杂志,2016,7(1):13-17.
• [13]章激.氯吡格雷联合阿司匹林治疗心脑血管疾病的研究进展[J].中国药房,2016,27(36):5182-5184.
• [14]王志永,齐向前,孙中华,等.阿司匹林联合小剂量氯吡格雷在PCI术后的临床应用[J].广西医科大学学报,2012,29(5):738-739.
• [15]贾珠银,杨建敏.替格瑞洛联合阿司匹林治疗急性冠状动脉综合征的临床研究[J].中国临床药理学杂志,2016,32(14):1254-1256,1282.
• [16]邹琪,曹霞,李莎恩.瑞舒伐他汀钙对急性冠脉综合征患者PCI术后IL-18、hs-CRP影响[J].现代仪器与医疗,2014,20(2):76-78.
• [17]杨贤义,刘梅,柴林,等.急性冠脉综合征患者行介入治疗后应用瑞舒伐他汀的临床价值[J].血栓与止血学,2017,23(4):580-583.
• [18]Patel D,Walitt B,Lindsay J,et al.Role of pioglitazone in the prevention of restenosis and need for revascularization after bare-metal stent implantation:a meta-analysis[J].JACCCardiovasc Interv,2011,4(3):353-360.
• [19]Jennings DL,Kalus JS.Addition of cilostazol to aspirin and a thienopyridine for prevention of restenosis after coronary artery stenting:A meta-analysis[J].J Clin Pharmacol April,2010,50(4):415-421.
• [20]马振,黄晓莉,关芳,等.冠状动脉介入治疗后再狭窄中医药研究进展[J].中国中医急症,2009,18(7):1144-1145.
• [21]孟伟,李本志,王希法,等.郭维琴辨治冠状动脉内支架植入术后再狭窄经验[J].中医杂志,2013,54(11):912-914.
• [22]乔志强,张敏州,程康林.邓铁涛治疗急性心肌梗死介入术后医案一则[J].中医杂志,2005,46(3):231-232.
• [23]靳宏光,齐锋,王义强,等.冠心病痰瘀证客观指标的临床研究[J].世界科学技术-中医药现代化,2013,15(5):1032-1035.
• [24]杨华,许臣洪,李欣.血府逐瘀汤加减对急性冠状动脉综合征患者经皮冠状动脉介入治疗后心血管事件的影响[J].中医杂志,2016,57(7):592-595.
• [25]王凯,张晶,杜亚君,等.血府逐瘀胶囊治疗老年急性心肌梗死患者PCI术后再狭窄的疗效观察[J].实用中西医结合临床,2015,15(2):3-5.
• [26]黄峻,李春坚,杨国平,等.通心络对兔外周血管球囊损伤后血栓形成及内膜增生的影响[J].中国临床药理学与治疗学,2001,6(1):35-38.
• [27]李妍伸,李和平,袁源,等.通心络胶囊对冠心病心绞痛患者介入治疗后的影响[J].世界中医药,2013,8(10):1251-1252.
• [28]陆宏伟,张健,陈欣,等.通心络胶囊联合西药预防经皮冠状动脉介入术后冠状动脉再狭窄90例临床观察[J].中医杂志,2014,55(24):2117-2120.
• [29]Cung TT,Morel O,Cayla G,et al.Cyclosporine before PCI in patients with acute myocardial infarction[J].N Engl J Med,2015,373(11):1021-1031.
• [30]van der Laan AM,Ter Horst EN,Delewi R,et al.Monocyte subset accumulation in the human heart following acute myocardial infarction and the role of the spleen as monocyte reservoir[J].Eur Heart J,2014,35(6):376-385.
• [31]Ye L,Chang YH,Xiong Q,et al.Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells[J].Cell Stem Cell,2014,15(6):750-761.
• [32]宋杰丽,曾锦培,张永霞,等.复方丹参滴丸联合阿托伐他汀对经皮冠状动脉腔内血管成形术后内膜增生的影响[J].南方医科大学学报,2014,34(9):1337-1341.
• [33]方芳,甘受益,冯光瑞,等.长期服用复方丹参滴丸对老年急性心肌梗死患者PCI术后左室重构及炎症因子水平的影响[J].现代生物医学进展,2017,17(3):544-546.
• [34]司新成,贾永平.麝香保心丸对冠脉造影介入术后的患者预后的影响[J].中医临床研究,2013,5(1):5-6.
• [35]蒋芳勇,孙立平,杨进,等.不同剂量血脂康对急性冠脉综合征患者PCI术后的影响[J].中国中西医结合杂志,2011,31(12):1607-1610.
• [36]李成伟,袁峰,李晓娟.芪参益气滴丸干预PCI术后急性前壁心肌梗死患者冠脉血流和左室功能的研究[J].中西医结合心脑血管病杂志,2014,(12):1441-1443.